Precision Chroma
1 known investors
Precision Chroma develops 3D-printed chromatography columns for purifying biological therapeutics, using patented 3D Printed Monolith Adsorption (PMA) technology with engineered hydrogels to process unclarified cell culture and other solids-laden fluids. The company serves the biopharmaceutical separations and protein purification market and is opening an early access programme.
BiotechDeep TechHardware
Investors · 1
Frequently asked questions
- What does Precision Chroma do?
- Precision Chroma develops 3D-printed chromatography columns for purifying biological therapeutics, using patented 3D Printed Monolith Adsorption (PMA) technology with engineered hydrogels to process unclarified cell culture and other solids-laden fluids. The company serves the biopharmaceutical separations and protein purification market and is opening an early access programme.
- Who are Precision Chroma's investors?
- Precision Chroma's investors include Bridgewest Ventures.